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Abstract
Background: HIV testing among risk groups and guided by HIV indicator conditions (IC) is widely recommended by
European guidelines. In this study we investigated how these strategies are used by general practitioners (GP) and in
other healthcare settings. The objectives of our study were to describe: 1) the proportion of consultations in primary
care and other healthcare settings in the five years prior to diagnosis; 2) patient and GP perspectives on the primary
healthcare providers’ awareness and registration of sexual orientation and ethnicity in the electronic medical record
(EMR); and 3) the proportion of HIV-infected patients who had been diagnosed with an IC prior to HIV diagnosis.
Methods: A survey study (2014–2016) was conducted among newly diagnosed HIV-infected patients presenting at
two HIV outpatient clinics in Amsterdam. We collected information on the number of consultations and extent of HIV
testing in healthcare settings in the 5 years prior to HIV diagnosis; on patient and GP perspectives on the primary
healthcare providers’ awareness of sexual orientation and ethnicity; and on preselected ICs and symptoms of acute HIV
infection prior to diagnosis. GPs were also approached for further information.
Results: In the 5 years prior to HIV diagnosis, 82.9% of the 111 patients had one or more consultations with their GP, but
only 34.8% had one or more HIV tests performed in general practice during this period. In more than 50% of cases the
patients took the initiative for the positive HIV test. GPs stated that they were aware of the sexual orientation of 59.6% of
their patients who were men who have sex with men (MSM); however, sexual orientation was only documented in the
EMR in 34.0% of these cases. GPs also reported that they were aware that a patient was from an HIV endemic country in
more than half of the cases. GPs diagnosed 48.3% of all ICs and 39.5% of this group was offered an HIV test at that time.
Conclusions: Documentation of sexual orientation and ethnicity, and IC-guided testing by GPs could be the starting
point for more proactive provider-initiated HIV testing.
Background
The number of people newly diagnosed with Human
Immunodeficiency Virus (HIV) in the Netherlands is still
approximately 1000 per year, the majority of whom (69%)
are men who have sex with men (MSM) [1]. In 2014, 44%
of those newly diagnosed with HIV in the Netherlands had
presented late for care (CD4 count < 350 cells/mm3 or with
an AIDS-defining event) [1]. Individuals from HIV endemic
countries had a higher likelihood of presenting late for care
[1]. This percentage was higher among females (53%) and
heterosexual males (66%) from HIV endemic countries
than in the MSM population (36%) [2]. Initiating treatment
after HIV diagnosis, regardless of CD4 count, improves the
prognosis of the person being treated and reduces trans-
mission [3–5]. These findings show the importance of early
detection and linkage to care.
Provider-initiated HIV testing among risk groups is
widely recommended by guidelines on sexually transmit-
ted infections (STIs)/HIV [6, 7]. A Dutch study showed
that 75% of the HIV-infected patients presenting late for
care had one or more risk factors for HIV recorded in
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the national STI guidelines [8]. Therefore, gathering in-
formation about patient sexual orientation or ethnicity is
important for a better HIV risk assessment [6]. General
practitioners (GPs) do not always collect this informa-
tion from their patients [9].
In order to reduce the number of undiagnosed cases of
HIV, as well as people presenting late for care, we need to
explore other provider-initiated HIV testing strategies.
HIV testing guided by indicator conditions (ICs) is a new
provider-initiated HIV testing strategy [7, 10]. The
European Centre for Disease Prevention and Control
(ECDC) recommends the routine offer of an HIV test in
patients with an IC, defined as: “1) conditions which are
AIDS-defining among people living with HIV; 2) conditions
associated with an undiagnosed HIV prevalence of > 0.1%;
and 3) conditions where not identifying the presence of
HIV infection may have significant adverse implications
for the individual’s clinical management despite the esti-
mated prevalence of HIV most likely being lower than
0.1% – for example, when aggressive immune-suppressive
therapy is considered (cancer or organ transplantation)”
[10]. A previous study conducted in Southeast Amsterdam
showed that prior to diagnosis, 58.8% of all HIV cases pre-
sented in primary care with one or more IC, compared to
7.4% of controls, revealing possible opportunities for more
provider-initiated HIV testing [11]. One important IC is
mononucleosis-like illness, which could indicate an acute
HIV infection, as 50 to 90% of people with the latter de-
velop a mononucleosis-like illness, which is often mis-
taken for flu or acute Epstein Barr virus infection [12, 13].
HIV testing among risk groups and HIV IC-guided
testing are widely recommended by international and
national guidelines [6, 7, 10]. In this study of newly diag-
nosed HIV-infected patients we collected more informa-
tion about how these strategies are used by GPs. The
objectives of our study were to describe: 1) the propor-
tion of consultations in primary care and other health-
care settings in the 5 years prior to diagnosis; 2) patient
and GP perspectives on the primary healthcare pro-
viders’ awareness and registration of sexual orientation
and ethnicity in the electronic medical record (EMR);
and 3) the proportion of HIV-infected patients with an
IC diagnosed by their GP prior to HIV diagnosis.
Methods
Data source
A survey study was conducted between January 2014 and
April 2016 at the HIV outpatient clinics of two hospitals
located in Amsterdam, the Netherlands. Patients newly di-
agnosed with HIV were eligible if they were 18 years or
older and presenting for the first time at these clinics.
We collected information by using paper question-
naires which addressed demographic characteristics
(gender, age), history of HIV testing, and number of
consultations in healthcare settings in the 5 years prior
to HIV diagnosis. The HIV-infected patients were also
asked if their GP was aware of their sexual orientation.
Furthermore, we collected information about ICs
diagnosed in a healthcare setting in the 5 years prior to
diagnosis [10].
The ECDC list of ICs was too long to be incorporated
in our questionnaire, and we therefore preselected a
small number of ICs (STIs, seborrheic dermatitis, oral
candidiasis, herpes zoster, cervix dysplasia and pneumo-
nia) that are observed in general practice. We also
included tuberculosis and HIV-related cancers.
Patients with a recent HIV infection (a negative or
undeterminate HIV test result less than 6 months prior
to diagnosis) were asked whether they had experienced a
mononucleosis-like illness in the 6 months prior to diag-
nosis; whether this illness was different to other flu-like
illnesses in the past; and whether they had contacted
their GP about this illness.
The HIV-infected patients were recruited by HIV
nurse practitioners experienced in counselling. GPs were
approached by phone for more information to determine
their awareness and registration of the patient’s sexual
orientation and, if applicable, whether they were aware
that the patient originated from an HIV endemic coun-
try. GPs were approached by one of the researchers (IJ)
involved in the study.
Additional information about the newly diagnosed
HIV-infected patients included in our study was ob-
tained from the ATHENA national observational HIV
cohort in the Netherlands, which monitors all people
registered as HIV positive in the 30 HIV treatment cen-
tres in the Netherlands, including four paediatric centres
[1]. Linkage to the ATHENA database was done using
an anonymized patient identifier. Additional data
included sociodemographic data (country of origin), de-
gree of urbanization, socioeconomic status (SES), clinical
data and CD4 cell count at the time of HIV diagnosis.
Level of urbanization and socioeconomic status were
defined as previously described [1, 2]. CD4 count at the
time of diagnosis was defined as the first CD4 count
within 3 months after diagnosis.
The medical ethics committees of both hospitals de-
clared that, according to the Medical Research Involving
Human Subjects Act (WMO), formal approval for this
research project by a medical ethics committee was not
required. The research was performed according to strict
guidelines for the privacy protection of patients and
GPs. All participants received information about the
study and gave their written consent.
Data analysis
Descriptive statistical methods were performed using
SPSS (SPSS version 19.0 software, IBM, USA).
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Results
Sociodemographic characteristics at HIV diagnosis
In total, 111 people were included in the study. Baseline
characteristics are presented in Table 1. The majority of
newly diagnosed HIV-infected patients (60.4%) were
MSM, while 19.4% (13/67) of this group (MSM), as well
as 66.7% (12/18) of females and 38.5% (10/26) of hetero-
sexual males, originated from HIV endemic countries.
Most were from moderate to highly urbanized areas and
58.5% had a higher than average SES status.
History of HIV testing
In the 5 years prior to HIV diagnosis, 21/109 patients
(19.3%) had not been tested for HIV (Table 2). In terms of
sociodemographics this can be broken into: 10.6% (7/66)
of the MSM group, 27.8% (5/18) of females, 36.0% (9/25)
of heterosexual males, and 25.7% (9/35) of patients origin-
ating from HIV endemic countries.
At diagnosis, 40 HIV-infected patients (37.4%) had a CD4
cell count ≤ 350 cells/mm3: 29.2% (19/65) of the MSM
group; 29.4% (5/17) of females; and 64.0% (16/25) of het-
erosexual males. Patients had taken the initiative for the
HIV (positive) test in more than half of the cases (56.4%).
The STI outpatient clinic (34.2%), general practice
(27.9%) and hospitals (26.1%) were all important settings
for diagnosing the HIV infection. In more than half of
the patients (51.9%), STI-related symptoms were the




Age at diagnosis, years
18–29 24 21.6
30–49 56 50.5
≥ 50 31 27.9
Gender and sexual orientation
MSM 67 60.4
Female 18 16.2
Heterosexual male 26 23.4




Highly urbanized 66 64.7
Urbanized 22 21.6
Moderately urbanized 7 6.9




Very wealthy 4 4.0
Wealthy 28 27.8
Average 27 26.7
Less favoured 18 17.8
Deprived 24 23.8
Missing 10
aPatients born in the Caribbean, Sub-Saharan Africa, South or Southeast Asia,
Latin/South America, North Africa, Middle East or Eastern Europe
Table 2 History of HIV testing
Total Number Percent
111
History of HIV testing
Never tested 21 19.3
Tested negative prior HIV diagnosis 86 78.9
Not sure 2 1.8
Missing 2
CD4 count at entry into care (cells/mm3)
≤ 350 40 37.4
350–500 21 19.6
≥ 500 46 43.0
Missing 4
Initiative for HIV positive test
Patient 62 56.4
Healthcare provider 48 43.6
Missing 1
Diagnosed at (setting)
General Practice 31 27.9
STI outpatient clinic 38 34.2
Hospital 29 26.1
Other 13 11.7
Reason for testing of the HIV positive test
STI-related symptoms 56 51.9
Routine health check 23 21.3
Pregnancy 5 4.6
At risk, own risk perception 4 3.7
At risk: sex with known HIV positive sex partner 3 2.8
At risk: contacted by a sex partner who tested HIV
positive
6 5.6
Anonymous notification of a sex partner of HIV
(by STI outpatient clinic)
Other 11 10.2
Missing 3
Refusal of HIV test in the past
Yes 1 0.9
No 110 99.1
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reason for HIV testing and 21.3% of the patients were
diagnosed by a routine health check.
Patient consultations in healthcare settings in the five
years prior to HIV diagnosis
In the 5 years prior to HIV diagnosis, the majority
(82.9%) of patients had one or more consultations with
their GP, and two-thirds had three or more consulta-
tions (Table 3). More than half (55.9%) visited one or
more medical specialists, 34.2% an emergency
department and 50.5% the outpatient STI clinic. In the
5 years prior to diagnosis, 34.8% of those who had
visited their GP had one or more HIV tests performed
in the general practice, compared to 85.7% of those
who visited an STI clinic.
GP knowledge and registration of sexual orientation in
the Electronic Medical Record
For 13 MSM, no contact with the GP was possible and four
people in this group refused permission to contact their
GP. Of the remaining GPs, 59.6% (28/47) reported that they
were aware of the sexual orientation of the patient (Table 4).
In contrast, 70.8% (34/48) of the MSM group reported that
the GP had knowledge of their sexual orientation.
In 71.4% (20/28) of the MSM group of which the GPs
were aware of their sexual orientation, no HIV test was
performed in the general practice prior to diagnosis,
compared to 78.9% (15/19) of the MSM group of which
the GP was not aware of their sexual orientation. The
sexual orientation was indeed documented in the EMR
of the GP in 34.0% (16/47) of the MSM cases.
Information was also collected about GP awareness of
patient origins in HIV endemic countries. For 14
patients from HIV endemic countries, no contact with
the GP was possible and two patients refused permission
to contact their GP. GPs reported that they were aware
that the patient was from an HIV endemic country in
56.3% (9/16) of patients from this group.
HIV indicator conditions and notification of GP of
mononucleosis-like illness
More than half (56.8%) of the patients had one or more
IC in the 5 years prior to HIV diagnosis: 35.1% (39/111)
had one IC; 12.6% (14/111) had two ICs; and 9.0% (10/
111) had three or more ICs. The most diagnosed ICs






One consultation 11 9.9
Two consultations 9 8.1
Three or more consultations 72 64.9





One medical specialist 34 30.6
Two medical specialist 16 14.4
Three or more medical specialists 12 10.8





One consultation 24 21.6
Two consultations 9 8.1
Three or more consultations 5 4.5





One consultation 16 14.4
Two consultations 8 7.2
Three or more consultations 32 28.9
One or more HIV tests performed prior to the HIV
diagnosis
48 85.7
Table 4 GP awareness and registration of sexual orientation
and ethnicity in the electronic medical record
Total Number Percent
MSM 50












Person originated from an HIV endemic country 19
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were STIs (68.0%), herpes zoster (11.7%) and seborrheic
dermatitis (8.7%). GPs diagnosed 48.3% (43/89, exclud-
ing 14 missing variables) of the ICs; 13.5% (12/89) of ICs
were diagnosed in hospitals; and 38.2% (34/89) in STI
clinics. Of the patients diagnosed with an IC by the GP,
39.5% (17/43) were offered an HIV test.
In 26.1% (29/111) of the patients, the HIV infection was
recent. Of these patients, 79.3% (23/29) were MSM or
originated from an HIV endemic country. Of this group,
88.5% (23/26) reported that they had a mononucleosis-
like illness in the 6 months prior to their diagnosis, with
73.9% (17/23) reporting that this illness was different to
other flu-like illnesses in the past. The GP was contacted
in 76.5% (13/17) of these cases of flu-like illness.
Discussion
In the 5 years prior to diagnosis, HIV-infected patients
had visited their GP more frequently than other health-
care providers, but only one-third of them had one or
more HIV tests performed in general practice. More
than half of the patients took the initiative themselves
for the HIV test that turned out positive.
Almost half of the GPs were not aware of the sexual
orientation of newly diagnosed MSM patients, even if
MSM themselves thought their GP was aware of their
sexual orientation. The sexual orientation was reported
in the GP’s EMR in one-third of the MSM group cases.
GPs reported that they were aware that the patient was
from an HIV endemic country for more than half of the
patients in this group.
GPs diagnosed around half of all ICs in the 5 years
prior to HIV diagnosis and 40% of these people were
offered an HIV test at the time of the IC diagnosis. The
majority of patients with a recent HIV infection reported
that they had a mononucleosis-like illness, and GPs were
frequently contacted about this flu-like illness.
Comparison with existing literature
Opportunities for provider-initiated HIV testing in pri-
mary care prior to HIV diagnosis have been described in
previous studies [11, 14–16]. GPs and patients may find
it difficult to discuss information about sexual orienta-
tion and ethnicity in detail, as this may be perceived as
discriminatory or stigmatizing [9, 17–21]. Moreover,
there is great diversity in sexual behaviour and identity,
even over time for individuals, and MSM may not always
identify themselves as such [22]. Our results showed
that, despite the belief of the patient, the GP is not
always aware of the patient’s sexual orientation. GPs reg-
istered the sexual orientation of their MSM patients in
the EMR in one-third of the cases. In the Netherlands,
no standard information about sexual orientation and
ethnicity is recorded in electronic medical records [23].
However, registration of this information may improve
the implementation of risk-based testing in primary care.
Registration of sexual orientation in the EMR is a sensi-
tive and complex issue [9, 19]. Where this information
should be recorded in these files remains a point of
discussion. In addition, GPs may not always have know-
ledge of the country of birth of a patient or connect this
with the list of HIV endemic countries [21, 24]. Our
results showed that, of the patients who originated in an
HIV endemic country, GPs were aware of 56% of the
cases. We recommend that opportunities to document
this culturally sensitive and gender-specific information
in the EMR are created.
European studies have demonstrated that patients with
well-established ICs should be recommended to have an
HIV test, as these ICs fulfil the criterion of having an HIV
prevalence > 0.1% (the threshold for cost-effectiveness)
[25, 26]. Another study has confirmed that HIV preva-
lence is higher than 0.1% for most of the ICs diagnosed in
primary care [27]. IC-guided testing is briefly mentioned
in the Dutch STI guidelines for GPs [6]. However, a previ-
ous Dutch study recommends better integration of rele-
vant ICs in STI guidelines for primary care [20]. Our
results found that GPs diagnosed around half of the ran-
domly preselected ICs, and only 40% of this group was of-
fered an HIV test at that time. The strength of IC-guided
testing is that it does not depend on HIV risk assessment
and could help GPs to bypass some of the barriers pre-
sented by complex conversations about sexually risky be-
haviour or ethnicity [20].
Strengths and limitations
This study was carried out among diagnosed HIV-infected
patients, and despite the number of patients being relatively
small, it offers some insight into the health-seeking behav-
iour of these patients. We combined real-life data from
patients and GPs to gain more evidence-based knowledge
about how provider-initiated strategies are used by general
practitioners.
Dutch or English-speaking HIV-infected patients were
eligible for this study. This may have introduced a selec-
tion bias, as it is possible that migrants who are at risk
of HIV but do not speak these languages may use other
health-seeking behaviour.
Finally, information from questionnaires may not
reflect all details of the patient’s healthcare history. As
data were collected retrospectively, socially desired
answers and recall bias cannot be excluded.
Conclusions
The documentation of sexual orientation, ethnicity and
IC-guided testing by GPs could be the starting point for
more proactive provider-initiated HIV testing.
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